Myriad Genetics MYGN Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's operating lease right-of-use assets in other assets?
- Myriad Genetics (MYGN) reported operating lease right-of-use assets in other assets of $51M in Q1 2026.
- How has Myriad Genetics's operating lease right-of-use assets in other assets changed year-over-year?
- Myriad Genetics's operating lease right-of-use assets in other assets decreased by 4.5% year-over-year, from $53.4M to $51M.
- What is the long-term trend for Myriad Genetics's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Myriad Genetics's operating lease right-of-use assets in other assets has grown at a -3.7% compound annual growth rate (CAGR), from $59.7M to $49.4M.